WNY Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
WNY Asset Management's BMY Position: Q1 2026 in Review
WNY Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 13,024 shares worth $790K. The stake represents 0.08% of the portfolio and ranks #116 among its holdings. This is a return to the name: WNY Asset Management previously reported a position in BMY as recently as Q3 2025.
WNY Asset Management first reported a position in BMY in Q4 2020 and has held it in 21 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- WNY Asset Management held 13,024 shares of Bristol-Myers Squibb worth $790K as of Q1 2026.
- Bristol-Myers Squibb was a new WNY Asset Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.08% of WNY Asset Management's portfolio in Q1 2026, its #116 holding.
- WNY Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 21 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on WNY Asset Management's 13F filing for Q1 2026, filed 22 May 2026.